Phase 2 Study to Evaluate Dose and Duration of Treatment

  • Manshaii, Sapoora (PI)

Project: Research project

Project Details

Description

Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated)Using Serial Measurements of Protein C in Patients with Severe Sepsis..
StatusFinished
Effective start/end date3/13/079/16/10

Funding

  • Eli Lilly and Company

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.